STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIMS
  4. [Form 4] Hims & Hers Health, Inc. Insider Trading Activity

HIMS Form 4: CMO Patrick Carroll Receives RSUs; 6,500 Shares Withheld

Patrick Harrison Carroll, Chief Medical Officer and director of Hims & Hers Health, Inc. (HIMS), reported transactions dated 09/15/2025 on Form 4.

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Patrick Harrison Carroll, Chief Medical Officer and director of Hims & Hers Health, Inc. (HIMS), reported transactions dated 09/15/2025 on Form 4. He was granted 16,521 RSUs that convert one-for-one into Class A common stock and additional RSU awards listed in the filing totaling 16,521 + 8,148 + 4,840 + 3,533 units across entries. The issuer withheld 6,500 shares to satisfy tax withholding at a reported price of $53.96, reducing reported Class A common stock beneficial ownership from 186,461 to 179,961 following the withholding. The RSUs are subject to service-based vesting schedules, generally over four years with quarterly vesting dates specified in the filing.

The filing is a reporting of equity awards and related withholding; it documents grant mechanics, vesting schedules, and post-transaction beneficial ownership levels but does not provide compensation totals in dollars beyond the withholding price or other company financial metrics.

Positive

  • RSU grants disclosed showing alignment of executive compensation with equity ownership
  • Detailed vesting schedules provided, specifying quarterly vesting over a four-year period

Negative

  • 6,500 shares withheld by the issuer to satisfy tax withholding, reducing direct beneficial ownership from 186,461 to 179,961
  • Form 4 contains no cash compensation totals or dollar-value aggregation of the awards beyond the withholding price

Insights

TL;DR: Routine RSU grants and tax-withholding reported; modest change in beneficial ownership, no cash proceeds or open-market sales disclosed.

The Form 4 documents service-based Restricted Stock Unit grants to an executive who is also a director, with vesting schedules over four years and quarterly vesting dates. The issuer withheld 6,500 shares to cover tax obligations at a stated price of $53.96, and the reporting persons reported direct Class A common stock decreased from 186,461 to 179,961 shares following withholding. The filing contains no information about exercise of options for cash, open-market dispositions, or additional compensation cash amounts.

TL;DR: Disclosure shows standard equity compensation mechanics and tax withholding; vesting schedules and insider status are clearly disclosed.

The reporting person is identified as both Chief Medical Officer and a director, and the Form 4 details multiple RSU grants with explicit service-based vesting schedules (4-year terms with quarterly vesting dates). The filing clearly states that RSUs convert one-for-one to Class A common stock and that shares were withheld for tax withholding. This is a routine insider disclosure consistent with equity-based compensation and Section 16 reporting requirements.

Insider Carroll Patrick Harrison
Role Chief Medical Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit 8,148 $0.00 $0.00
Exercise Restricted Stock Unit 4,840 $0.00 $0.00
Exercise Restricted Stock Unit 3,533 $0.00 $0.00
Exercise Class A Common Stock 16,521 $0.00 $0.00
Exercise Price or Tax Liability Class A Common Stock 6,500 $53.96 $351K
Holdings After Transaction: Restricted Stock Unit — 138,603 contracts (Direct); Class A Common Stock — 179,961 shares (Direct)
Footnotes (6)
  1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
  2. F2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
  3. F3. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter.
  4. F4. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
  5. F5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
  6. F6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who filed the Form 4 for HIMS?
The filing was made on behalf of Patrick Harrison Carroll, Chief Medical Officer and director of Hims & Hers Health, Inc.

What transactions were reported on the Form 4 dated 09/15/2025 for HIMS?
The Form 4 reports grants of RSUs (including 16,521 RSUs on 09/15/2025) and withholding of 6,500 Class A shares to cover tax obligations at $53.96 per share.

How did beneficial ownership change after the reported transactions?
Reported direct Class A common stock beneficial ownership decreased from 186,461 to 179,961 following the withholding.

What are the vesting terms for the RSUs disclosed?
The RSUs are subject to service-based vesting over a 4-year period with quarterly vesting dates (March 15, June 15, September 15, December 15) as specified in the filing.

Was any open-market sale or cash exercise reported?
No open-market sale or cash exercise of options is reported; only RSU grants and share withholding for tax are disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Carroll Patrick Harrison
(Last) (First) (Middle)
2269 CHESTNUT STREET, #523
(Street)
SAN FRANCISCO CA 94123
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Medical Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/15/2025 M 16,521 A (1) 186,461 D
Class A Common Stock 09/15/2025 F 6,500(2) D $53.96 179,961 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 09/15/2025 M 8,148 (3) (3) Class A Common Stock 8,148 $0 40,744 D
Restricted Stock Unit (4) 09/15/2025 M 4,840 (5) (5) Class A Common Stock 4,840 $0 48,396 D
Restricted Stock Unit (4) 09/15/2025 M 3,533 (6) (6) Class A Common Stock 3,533 $0 49,463 D
Explanation of Responses:
1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
3. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter.
4. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Patrick Harrison Carroll 09/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

Keep reading

More on HIMS

Trending in the feed

Open the live feed